Diabetes mellitus Flashcards

1
Q

Compare and contrast LADA vs MODY.

A

LADA - latent autoimmune diabetes in adults; a type of type 1 diabetes which is diagnosed later than the typical onset of type 1 (and so commonly mistaken for T1DM). Progress to insulin requirement within 6 years; may have other autoimmune conditions and have antibodies and low C-peptide.

MODY - maturity onset diabetes of the young; a type of T2DM but commonly mistaken for type 1 as onset is early but there are no antibodies present and usually no insulin requirement. Usually family history present as monogenic autosomal dominant inheritance.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Define type 2 diabetes.

A

Common disorder characterised by insulin resistance and relative insulin deficiency. Most patients are asymptomatic and are diagnosed through screening (abnormal fasting plasma glucose, haemoglobin A1c, and/or oral glucose tolerance test)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Define type 1 diabetes mellitus.

A

Characterised by absolute insulin deficiency. Most cases result from autoimmune pancreatic beta-cell destruction in genetically susceptible individuals. Usually presents with acute symptoms or ketoacidosis in childhood or adolescence. Lifelong insulin therapy is required.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Broadly describe diabetes mellitus.

A

DM results from lack, or reduced effectiveness, of endogenous insulin. Hyperglycaemia is one aspect of a far-reaching metabolic derangement, which causes serious microvascular or macrovascular problems.

So think of DM as a vascular disease: adopt a holistic approach and consider other cardiovascular risk factors too.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

How common is type 1 DM? Who is usually affected?

A
  • Type 1 diabetes accounts for about 5% to 10% of all patients with diabetes
  • Most commonly diagnosed diabetes of youth (under 20 years of age) and causes ≥85% of all diabetes cases in this age
  • Geographical variation - more common in Europeans and less common in Asians
  • Worldwide, incidence is increasing by 3% every year, although the reasons for this are unclear
  • Affects M&F equally
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the cause of type 1 DM?

A

Insulin deficiency from autoimmune destruction of insulin-secreting pancreatic β‎ cells

Associated with other autoimmune diseases (>90% HLA DR3± DR4). Concordance is only ~30% in identical twins, indicating environmental influence.

Four genes are important: one (6q) determines islet sensitivity to damage (eg from viruses or cross-reactivity from cows’ milk-induced antibodies).

Latent autoimmune diabetes of adults (LADA) is a form of type 1 DM, with slower progression to insulin dependence in later life.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the causes of type 2 DM? What types exist?

A

(non-insulin-dependent DM)

↓insulin secretion ± ↑insulin resistance.

  • It is associated with obesity, lack of exercise, calorie and alcohol excess.
  • ≳80% concordance in identical twins, indicating stronger genetic influence than in type 1 DM.
  • Typically progresses from a preliminary phase of IGT or IFG. (This is a unique window for lifestyle intervention.)
  • Maturity onset diabetes of the young (MODY) is a rare autosomal dominant form of type 2 DM affecting young people.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

How common is type 2 DM? Who is usually affected?

A
  • At ‘epidemic’ levels in many places, mainly due to lifestyle but also due to better diagnosis and improved longevity. Trends in incidence rate of diabetes has plateaued and now appears to be decreasing.
  • 90% of cases of diabetes are type 2
  • Higher prevalence in Asians, men and the elderly (up to 18%)
  • Most are over 40yrs, but teenagers are becoming affected
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is impaired glucose tolerance?

A
  • IGT is fasting plasma glucose <7mmol/L
  • and OGTT 2hr glucose _>7.8mmol/L but <11.1mmol/L (_7.8-11.1mmol/L)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is impaired fasting glucose?

A

IFG is fasting plasma glucose between 6.1-7.0mmol/L (but not including these numbers)

Do an OGTT to exclude DM.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is a normal, pre-diabetic and diabetic HbA1c level?

A

normal - <42mmol/mol

pre-diabetic - 43-47 mmol/mol

diabetic - >47mmol/mol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is the difference between IFG and IGT>

A
  • IGT - post-prandial glucose regulation
  • IFG - fasting glucose regulation

Lower incidence of progression to DM in IFG than IGT. If IFG and HbA1c at high end of normal range then incidence of DM is 25%.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Name some unusual causes of DM.

A

Steroids - anti HIV drugs, newer antipsychotics

Pancreatic - pancreatitis, surgery (if >90% removed), trauma, pancreatic destruction (haemochromatosis, cystic fibrosis), cancer.

Cushing’s disease - acromegaly, phaeochromocytoma, hyperthyroidism, pregnancy

Other - congenital lipodystrophy, glycogen storage disroders

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Define metabolic syndrome (syndrome x).

A

Definition from International Diabetes Federation:

  • central obesity (BMI>30, or ↑waist circ, ethnic-specific values)…

…plus two of:

  • BP≥130/85,
  • triglycerides ≥1.7mmol/L,
  • HDL≤1.03♂/1.29♀mmol/L,
  • fasting glucose ≥5.6mmol/L
  • or type2 DM.

~20% are affected; weight, genetics, and insulin resistance important in aetiology. Vascular events—but probably not beyond the combined effect of individual risk factors.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the WHO criteria for diagnosis of DM?

A
  • Symptoms of hyperglycaemia (e.g. polyuria, polydipsia, unexplained weight loss, visual blurring, genital thrush, lethargy)
  • AND raised venous glucose detected once - fasting >7mmol/L or random >11.1mmol/L

OR

  • Raised venous glucose on 2 separate occassions - fasting >7mmol/L, random >11.1mmol/L OR OGTT 2hr value >11.1mmol/L

OR

  • HbA1c >47mmol/mol (avoid in pregnancy, children, type 1 DM, haemoglobinopathies)
  • Try to do a blood glucose each time you’re taking blood - non systematic but better than urine tests which have high false -ve rate.*
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Name 4 differences between type 1 and type 2 DM.

A

Type 1 - usually weight loss, persistent hyperglycaemia despite diet and medication; autoantibodies (islet cell antibbodies ICA and anti-glutamic acid decarboxylase GAD antibodies), ketonuria.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

When should you suspect LADA?

A

Type 2 - not always old, ketotic, poor response to hypoglycaemics (and slim with FH of autoimmunity) think of LADA and measure islet cell antibodies.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What is the best diet for obese patients with type 2 DM?

A

Low-carbohydrate diets - improve glycaemic control

LCKD - low carbohydrate, ketogenic diets = <20g carbohydrate per day show greater improvement in HbA1c, weight and HDL than low calorie diets alone. They also reduce need for medication.

Low calorie diets can also be helpful - deficit of 500kcal/day

19
Q

Name 3 ways of monitoring glucose control.

A

Fingerprick (if on insulin)

  • before meal - informs about long-acting insulin doses
  • after meal - informs about dose of short acting insulin

Glycated haemoglobin (HbA1c) - relates to mean glucose level over 8wks (RBC half-life). Targets negotiable (e.g. 48-57mmol/mol) depending on patient e.g. if at risks of hypoglycaema falls consider less tight control. But complications rise with rising HbA1c.

Hypoglycaemic attacks - ask about symptoms. Hypoglycaemic awareness may diminish if control is too tight, or with time in type 1 DM due to reduced glucagon secretion. May return if control is loosened.

20
Q

What is the general management non-medical of diabetes?

A
  1. Education and lifestyle advice - exercise to increase insulin sensitivity, health eating (less sugar, saturated fats, modrate protein, more starch carbs)
  2. Bariatric surgery could cure DM in selected patients
  3. Assess global vascular risk - statin, control BP
  4. Foot care
  5. Advise informing DVLA if hypoglycaemic spells - loss of hypoglycaemic awareness may lead to loss of license
21
Q

What types of subcutaenous insulins are available for type 1 DM?

A
  1. Ultra-fast acting - e.g. Humalog, Novorapid - inject at start or meal or just after, helps match with what is actually eatenn not planned.
  2. Isophane insulin - peak at 4-12hrs, cheap
  3. Pre-mixed insulins - e.g. NovoMix 30 is 30% short-acting and 70% long-acting insulin
  4. Long acting recombinant human insulin analogue - e.g. insulin glargine - used at bedtme in type 1 or 2. No awkward peak, so good for nocturnal hypoglycaemia.
    • insulin detemir - similar and has role in intenstive regimens in overweight type 2 DM patients.
22
Q

List some common insulin regimens.

A
  1. BD - biphasic regimen - BD premixed insulins by pen (e.g. NovoMix 30) - useful in type 1 or 2 with regular lifestyle
  2. QDS - before meals (ultra-fast) + bedtime (long-acting analogue) - useful for type 1 with flexible lifestyle.
  3. Once-daily before bed long-acting insulin - good when switching to insulin from tablets in type 2. More than or = 1u/24hr for every unit of BMI. Consider keeping metformin +- pioglitazone with it if tight control needed and unable to use BD routine.
23
Q

What is DAFNE?

A

Dose Adjustment For Normal Eating - a way of managing Type 1 diabetes for adults and provides the skills necessary to estimate the carbohydrate in each meal and to inject the right dose of insulin. It is taught through a course. It helps peaople live the most normal life possible whilst keeping glucose levels stable.

24
Q

When would you consider using an insulin pump in a patient?

A

When attempts to reach Hba1c with multiple daily injections have resulted in disabling hypoglycaemia or person has been unable to achieve target Hba1c despite careful management.

25
Q

How do you manage diabetes in an illness?

A
  • More insulin will be required despite reduced food intake
  • Maintain calorie intake e.g. using milk
  • Check blood glucose >4 times/day and check for ketonuria - adjust insulin. Advise to get help from specialist nurse or GP. Could take 2hourly fast-acting insulin (e.g. 6-8u) preceded by fingerprick glucose.
  • Admit if vomiting, dehydrated, ketotic, child or pregnant.
26
Q

Summarise the management of type 2 DM.

A
27
Q

List some medical treatment options for type 2 diabetes.

A

Oral hypoglycaemic agents:

  1. Metformin - a biguanide
  2. DPP4 inhibitors/gliptins - e.g. sitagliptin
  3. Glitazone
  4. Sulfonylurea
  5. SGLTI - selective sodium–glucose co-transporter-2 inhibitor e.g. empagliflozin

Incretin mimetics

  1. GLP- glucagon-like peptide analogue e.g. exenatide, liraglutide
28
Q

How do gliptins work?

A

Gliptin = DPP4 inhibitor

Enzyme which destroys the hormone incretin

29
Q

How does metformin work? What are the 2 side effects? Does it cause hypoglycaemia? When should you avoid it?

A

Metformin = a biguanide, increases insulin sensitivity and helps weight

SE : nausea, diarrhoea, abdominal pain

Does NOT cause hypoglycaemia

Avoid: if EGFR is <36ml/min due to risk of lactic acidosis.

30
Q

How does glitazone work? Name 2 side effects. Does it cause hypoglycaemia? When should you avoid it?

A

Glitazone - increases insulin sensitivity

SE: hypoglycaemia, fractures, fluid retention, increased LFTs (doe LFT every 8wks for a year; stop if ALT up 3 fold)

Contraindications: past or present congestive cardiac failure, osteoporosis, monitor weight and stop if gaining weight or oedema.

31
Q

How do sulfonylureas work? Name 2 side effects. Does it cause hypoglycaemia?

A

Increases insulin secretion

e.g. gliclazide 40mg/d

SE: hypoglycaemia, weight gain

32
Q

How do SGLTI work? What is a major benefit of these drugs?

A
  • Selective sodium-glucose co-transporter 2 inhibitors
  • Block reabsorption of glucose in the kidneys and so promite excretion of excess glucose in the urine (e.g. empagliflozin)

BENEFIT: reduces CVD mortality

33
Q

How do GLP analogues work? When would you consider giving these injections? When do you consider keeping them?

A

E.g. exenatide, liraglutide

  • Work at incretin memetics - incretins are gut peptides that increase insulin release
  • Sub cutaneous injection

Patients must:

  • have BMI>35 and psychological/other medical problems associated with obesity
  • OR BMI<35kg/m2 but insulin therapy would have occupational implications or weight loss would significantly benefit other obesity-related co-morbidities

To continue a patient should have a beneficial metabolic response:

  • reduction of HbA1c by at least 11mmol/mol
  • weight loss of at least 3% initial body weight in 6 months
34
Q

When should you control BP in diabetes? What drugs would you use?

A

Type 1

  • Treat if BP >135/85mmHg
  • OR if >130/80mmHg + albuminuria +/- features of metabolis syndromes
    • Use ACEi first line
    • OR ARB if intolerant
    • DO NOT OFFER ASPIRIN for type 1 CVD prevention

Type 2

  • Treat if BP >140/80mmHg
  • OR >130/80mmHg + kidney/eye/cerebrovascular damage
    • ACEi first line
    • except in African/Caribbean use ACEi+diuretic OR calcium channel antagonist
      *
35
Q

What are the complications of diabetes?

A
  • Injection site lipohypertrophy
  • Vascular disease:
    • Stroke - x2 risk
    • MI - x4 risk
    • loss of foot pulses –> ulceration
  • Nephropathy
    • microalbuminuria (-ve dipstick but urine albumin:Cr ratio is >3)
  • Retinopathy/cataracts/rubeosis iridis
  • Diabetic foot
    • Charcot joint
  • Neuropathy
    • pain/sharp touch and vibration are lost first
    • ‘glove & stocking’ numbness, tingling, and pain, eg worse at night
36
Q

What shoud you give to prevent vascular disease?

A

Statin - atorvastatin 20mg nocte

Aspirin - 75mg (not in type 1)

37
Q

Which drug can help with microalbuminuria/nephropathy?

A

RAA inhibitor e.g. ACEi like ramipril or a sartan even if BP is normal

38
Q

List the 4 types of diabetic retinopathy.

A

Background retinopathy - microaneurysms (dots), haemorrhages (blots), hard exudates (lipid deposits)

Pre-proliferative retinopathy - cotton-wool spots (e.g. infarcts), haemorrhages, venous beading

Proliferative retinopathy - new vessels form

Maculopathy - hard to see in early stages but suspect if reducedd acuity. Caused by high retinal blold flow caused by hyperglycaemia. New vessels near disc, proliferate, bleed and fibrose and can detach retina. Capillary pericyte damage.

39
Q

How do you treat diabetic neuropathies?

A
  1. paracetamol
  2. → tricyclic (amitriptyline 10–25mg nocte; gradually ↑ to 150mg)
  3. → duloxetine, gabapentin, or pregabalin
  4. → opiates.
40
Q

Why might you get blurred vision in diabetes?

Why are pioglictazone/gliclazide given as add on therapy rather than first line?

A

Osmotic effecs on the lens of the eye may alter refraction and blur vision

Metformin is first line as the others can promote weight gain so only given as add on therapy.

41
Q

Name 2 side effects of metformin.

A
  • Diarrhoea
  • Lactic acidosis

Not fluid retention, not hypoglycaemia as it works by decreasing hepatic glucose output.

42
Q

Which of these forms part of the yearly diabetic review?

  1. Urine albumin:creatinine ratio
  2. Urine protein:creatinine ratio
  3. Stop ACE inhibitors
  4. Advise low protein diet
  5. Check for glaucoma
A

1

Patients with type 2 diabetes should have yearly retinopathy screening, foot assessment for both sensation and doppler testing of vascular supply, albumin:creatinie ratio, U+E, serum cholesterol, HBa1c and review of any glucose monitoring, weight assessment, and smoking status assessment.

43
Q

How do you ensure that ACE inhibitor therapy in a patient with suspected renal artery stenosis isn’t causing AKI?

A

U+E is taken after 10-14 days to ensure no more than a 20% rise in serum creatinine has occurred.

A rise of >20% would indicate that the patient MAY have significant renal artery stenosis and the drug should be stopped and consideration given to imaging the renal arteries